Impact of breast cancer treatment on fertility

Breast Cancer Research and Treatment

Volumn 123, Issue SUPPL. 1, 2010, Pages 59-63

  De La Haba Rodríguez, Juan ^a   Calderay, Milagros ^b  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; BUSULFAN; CHLORAMBUCIL; CHLORMETHINE DERIVATIVE; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GONADORELIN; MELPHALAN; METHOTREXATE; PACLITAXEL; PROCARBAZINE; VINCA ALKALOID;

AMENORRHEA; ANXIETY DISORDER; ARTHRALGIA; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER THERAPY; CARDIOVASCULAR DISEASE; CELL CYCLE ARREST; CHEMOTHERAPY INDUCED AMENORRHEA; CLINICAL TRIAL; CRYOPRESERVATION; DEPRESSION; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FEMALE STERILITY; FERTILIZATION IN VITRO; HOT FLUSH; HUMAN; INCIDENCE; INSOMNIA; OSTEOPOROSIS; OVARIAN PRESERVATION; OVARY INSUFFICIENCY; OVULATION INDUCTION; PRIORITY JOURNAL; REVIEW; SEXUAL DYSFUNCTION; UROGENITAL TRACT DISEASE;

ADULT; AGE FACTORS; AMENORRHEA; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CRYOPRESERVATION; FEMALE; FERTILITY; GONADOTROPIN-RELEASING HORMONE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFERTILITY; INFERTILITY, FEMALE; MENSTRUATION; OVARIAN FOLLICLE; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; PRIMARY OVARIAN INSUFFICIENCY; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 77957699231     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1069-7     Document Type: Review

References (39)

1. BF Hankey B Miller R Curtis C Kosary 1994 Trends in breast cancer in younger women in contrast to older women J Natl Cancer Inst Monogr 16 7 14 7999473
2. S Gelber AS Coates A Goldhirsch M Castiglione-Gertsch G Marini J Lindtner, et al. 2001 Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer J Clin Oncol 19 6 1671 1675 1:STN:280:DC%2BD3M3gsl2gug%3D%3D 11250996
3. M Sonmezer K Oktay 2006 Fertility preservation in young women undergoing breast cancer therapy Oncologist 11 5 422 434 1:CAS:528:DC%2BD28XhtFGhu7jJ 10.1634/theoncologist.11-5-422 16720842
4. PA Ganz GA Greendale 2001 Menopause and breast cancer: addressing the secondary health effects of adjuvant chemotherapy J Clin Oncol 19 14 3303 3305 1:STN:280:DC%2BD3MvgtlKgtA%3D%3D 11454876
5. GL Warne KF Fairley JB Hobbs FI Martin 1973 Cyclophosphamide-induced ovarian failure N Engl J Med 289 22 1159 1162 1:STN:280:DyaE2c%2FjsFSltQ%3D%3D 10.1056/NEJM197311292892202 4754963
6. P Poikonen T Saarto I Elomaa H Joensuu C Blomqvist 2000 Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients Eur J Cancer 36 1 43 48 1:CAS:528:DC%2BD3cXks1Citw%3D%3D 10.1016/S0959-8049(99)00225-7 10741293
7. DC Tormey R Gray MD Abeloff DL Roseman KW Gilchrist EJ Barylak, et al. 1992 Adjuvant therapy with a doxorubicin regimen and long-term tamoxifen in premenopausal breast cancer patients: an Eastern Cooperative Oncology Group trial J Clin Oncol 10 12 1848 1856 1:STN:280:DyaK3s%2FosFertw%3D%3D 1453199
8. A Goldhirsch RD Gelber M Castiglione 1990 The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group Ann Oncol 1 3 183 188 1:STN:280:DyaK3M%2FosVakug%3D%3D 2261364
9. O Pagani A O'Neill M Castiglione RD Gelber A Goldhirsch CM Rudenstam, et al. 1998 Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI Eur J Cancer 34 5 632 640 1:STN:280:DyaK1cznvVyrug%3D%3D 10.1016/S0959-8049(97)10036-3 9713266
10. MA Richards SM O'Reilly A Howell WD George IS Fentiman MA Chaudary, et al. 1990 Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial J Clin Oncol 8 12 2032 2039 1:STN:280:DyaK3M%2FjvVajtg%3D%3D 2230895
11. E Marhhom I Cohen 2007 Fertility preservation options for women with malignancies Obstet Gynecol Surv 62 1 58 72 10.1097/01.ogx.0000251029.93792.5d 17176489
12. L Del Mastro T Catzeddu M Venturini 2006 Infertility and pregnancy after breast cancer: current knowledge and future perspectives Cancer Treat Rev 32 6 417 422 10.1016/j.ctrv.2006.05.004 16842927
13. H Brincker C Rose F Rank HT Mouridsen A Jakobsen P Dombernowsky, et al. 1987 Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer J Clin Oncol 5 11 1771 1778 1:STN:280: DyaL1c%2FmtFCrsQ%3D%3D 3316514
14. K Oktay M Sonmezer 2007 Fertility preservation in gynecologic cancers Curr Opin Oncol 19 5 506 511 10.1097/CCO.0b013e3282a14eae 17762579
15. I Demeestere P Simon Y Englert A Delbaere 2003 Preliminary experience of ovarian tissue cryopreservation procedure: alternatives, perspectives and feasibility Reprod Biomed Online 7 5 572 579 10.1016/S1472-6483(10)62074-3 14680552
16. WR Parulekar AG Day JA Ottaway LE Shepherd ME Trudeau V Bramwell, et al. 2005 Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study-NCIC CTG MA.5 J Clin Oncol 23 25 6002 6008 10.1200/JCO.2005.07.096 16135468
17. PJ Goodwin M Ennis KI Pritchard M Trudeau N Hood 1999 Risk of menopause during the first year after breast cancer diagnosis J Clin Oncol 17 8 2365 2370 1:STN:280:DC%2BD3c%2FjtVShtQ%3D%3D 10561298
18. DR Budman DA Berry CT Cirrincione IC Henderson WC Wood RB Weiss, et al. 1998 Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B J Natl Cancer Inst 90 16 1205 1211 1:CAS:528:DyaK1cXlslylt7w%3D 10.1093/jnci/90.16.1205 9719081
19. P Fumoleau P Kerbrat P Romestaing P Fargeot A Bremond M Namer, et al. 2003 Randomized trial comparing six versus three cycles of epirubicin-based adjuvant chemotherapy in premenopausal, node-positive breast cancer patients: 10-year follow-up results of the French Adjuvant Study Group 01 trial J Clin Oncol 21 2 298 305 1:CAS:528:DC%2BD2cXpsVWqs7s%3D 10.1200/JCO.2003.04.148 12525522
20. M Martin T Pienkowski J Mackey M Pawlicki JP Guastalla C Weaver, et al. 2005 Adjuvant docetaxel for node-positive breast cancer N Engl J Med 352 22 2302 2313 1:CAS:528:DC%2BD2MXksl2lt7c%3D 10.1056/NEJMoa043681 15930421
21. SM Swain SR Land MW Ritter JP Costantino RS Cecchini EP Mamounas, et al. 2009 Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide- followed-by-docetaxel arm of NSABP B-30 trial Breast Cancer Res Treat 113 2 315 320 1:CAS:528:DC%2BD1MXhsVKguw%3D%3D 10.1007/s10549-008-9937-0 18302020
22. SJ Lee LR Schover AH Partridge P Patrizio WH Wallace K Hagerty, et al. 2006 American Society of Clinical Oncology recommendations on fertility preservation in cancer patients J Clin Oncol 24 18 2917 2931 10.1200/JCO.2006.06.5888 16651642
23. BJ Bankowski AD Lyerly RR Faden EE Wallach 2005 The social implications of embryo cryopreservation Fertil Steril 84 4 823 832 10.1016/j.fertnstert.2005. 02.057 16213829
24. SS Kim 2006 Fertility preservation in female cancer patients: current developments and future directions Fertil Steril 85 1 1 11 1:CAS:528: DC%2BD28XjvVGhu7k%3D 10.1016/j.fertnstert.2005.04.071 16412718
25. MJ Pelinck A Hoek AH Simons MJ Heineman 2002 Efficacy of natural cycle IVF: a review of the literature Hum Reprod Update 8 2 129 139 1:STN:280:DC%2BD38zls1Wnsw%3D%3D 10.1093/humupd/8.2.129 12099628
26. RF Casper 2007 Aromatase inhibitors in ovarian stimulation J Steroid Biochem Mol Biol 106 1-5 71 75 1:CAS:528:DC%2BD2sXhtVWitbbO 10.1016/j.jsbmb. 2007.05.025 17604615
27. J Donnez P Jadoul J Squifflet A Van Langendonckt O Donnez AS Van Eyck, et al. 2009 Ovarian tissue cryopreservation and transplantation in cancer patients Best Pract Res Clin Obstet Gynaecol 24 1 87 100 10.1016/j.bpobgyn.2009.09.003 19850531
28. SS Kim DE Battaglia MR Soules 2001 The future of human ovarian cryopreservation and transplantation: fertility and beyond Fertil Steril 75 6 1049 1056 1:STN:280:DC%2BD3MzhtFyguw%3D%3D 10.1016/S0015-0282(01)01790-3 11384626
29. Novella-Maestre E, Sánchez M (2009) Estadop actual de la congelación de la corteza ovárica. In: García Velasco JA (ed) Cuadernos de Medicina Reproductiva, p 83-90
30. Tocino A, Sánchez M, Caligara Z (2009) Uso de los análogos de la GnRH en la preservación de la fertilidad. In: García Velasco JA (ed) Cuadernos de Medicina Reproductiva, p 61-69
31. B Gerber M Dieterich H Muller T Reimer 2008 Controversies in preservation of ovary function and fertility in patients with breast cancer Breast Cancer Res Treat 108 1 1 7 10.1007/s10549-007-9572-1 17457668
32. WK So JC Cheng SL Poon PC Leung 2008 Gonadotropin-releasing hormone and ovarian cancer: a functional and mechanistic overview FEBS J 275 22 5496 5511 1:CAS:528:DC%2BD1cXhsVWktrfF 18959739
33. K Manger L Wildt JR Kalden B Manger 2006 Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study Autoimmun Rev 5 4 269 272 1:CAS:528:DC%2BD28XmtlKgsLo%3D 10.1016/j.autrev.2005.10.001 16697968
34. M Castiglione-Gertsch A O'Neill KN Price A Goldhirsch AS Coates M Colleoni, et al. 2003 Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial J Natl Cancer Inst 95 24 1833 1846 14679153
35. G Bonadonna A Moliterni M Zambetti MG Daidone S Pilotti L Gianni, et al. 2005 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study BMJ 330 7485 217 10.1136/bmj.38314.622095.8F 15649903
36. H Roche P Kerbrat J Bonneterre P Fargeot P Fumoleau A Monnier, et al. 2006 Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial Ann Oncol 17 8 1221 1227 1:STN:280:DC%2BD28vkvVOkuw%3D%3D 10.1093/annonc/mdl107 16731539
37. M Berliere F Dalenc N Malingret A Vindevogel P Piette H Roche, et al. 2008 Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel BMC Cancer 8 56 10.1186/1471-2407-8-56 18291033
38. YL Tham K Sexton H Weiss R Elledge LC Friedman R Kramer 2007 The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane Am J Clin Oncol 30 2 126 132 1:CAS:528:DC%2BD2sXltFWjsLc%3D 10.1097/01.coc.0000251398.57630.4f 17414460
39. JA Perez-Fidalgo S Rosello E Garcia-Garre E Jorda P Martin-Martorell B Bermejo, et al. 2010 Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens Breast Cancer Res Treat 120 1 245 251 10.1007/s10549-009-0426-x 19575291